What is the ticker symbol for Vor Biopharma?

Vor Biopharma trades under the ticker VOR on NASDAQ.

What sector does Vor Biopharma operate in?

Vor Biopharma is classified in the Healthcare sector (Biotechnology industry).

How can PortView help analyze VOR in a portfolio?

PortView shows VOR's weight in your portfolio, its contribution to return and risk, sector exposure, indirect exposure through ETFs you own, and correlation with your other holdings.

Vor Biopharma (VOR) Stock Analysis

NASDAQHealthcareBiotechnology

$24.18+6.80%

1-year price historyRange $6.86 – $48.72

52-week range$24.18

$6.50$49.95

What Vor Biopharma does

Vor Biopharma, Inc. is a clinical-stage biotechnology firm dedicated to developing innovative engineered hematopoietic stem cell (eHSC) therapies for individuals battling cancer. Its lead product candidate, VOR33, is an eHSC therapy currently undergoing Phase 1/2 clinical trials. VOR33 is designed to target acute myeloid leukemia (AML) and various other hematological malignancies. A key feature of VOR33's eHSCs is their engineered absence of the CD33 protein, which is commonly found on AML blood cancer cells. The company's eHSC platform is intended to enable a range of targeted blood cancer treatments, including CAR-T cell therapies, bispecific antibodies, and antibody-drug conjugates. Vor Biopharma has established a partnership with Akron BioProducts for the development and manufacturing of cGMP nucleases. Established in 2015, the company's headquarters are located in Cambridge, Massachusetts.

Key metrics

Market cap

$1.31B

P/E (TTM)

-7.65

EPS (TTM)

$-3.16

Beta

1.72

Dividend yield

0.00%

Revenue / share

$0.00

50-day avg

$20.60

200-day avg

$15.42

52-week high

$49.95

52-week low

$6.50

CEO

Jean-Paul Kress

ETFs linked to VOR

Broad-market and Healthcare sector ETFs an investor holding Vor Biopharma is often also exposed to. Open an ETF page to see its actual top holdings.

SPY — SPDR S&P 500 ETF Trust VOO — Vanguard S&P 500 ETF QQQ — Invesco QQQ Trust VTI — Vanguard Total Stock Market ETF

PortView Portfolio Insights

PortView analyzes how VOR fits your actual portfolio — position weight, portfolio concentration, unrealized gain/loss, contribution to return, sector exposure, indirect exposure through the ETFs you hold, and correlation with your other holdings. Connect a portfolio to see your personalized figures; PortView never shows another user's private holdings.

Analyze VOR in PortView →

Similar companies

JNJ — Johnson &LLY — Eli Lilly A — Agilent Technologies ABBV — AbbVie Inc.ABT — Abbott Laboratories ALNY — Alnylam Pharmaceuticals

Frequently asked questions

What is the ticker symbol for Vor Biopharma?: Vor Biopharma trades under the ticker VOR on NASDAQ.
Which exchange is VOR listed on?: VOR is listed on NASDAQ.
What sector does Vor Biopharma operate in?: Vor Biopharma is classified in the Healthcare sector (Biotechnology industry).
How can PortView help analyze VOR in a portfolio?: PortView shows VOR's weight in your portfolio, its contribution to return and risk, sector exposure, indirect exposure through ETFs you own, and correlation with your other holdings.

The information provided by PortView is for informational and educational purposes only and does not constitute investment advice. Market data may be delayed. Past performance does not guarantee future results.